Cargando…
Erythropoietin promotes the growth of pituitary adenomas by enhancing angiogenesis
rhEPO is frequently used in clinical practice to treat anemia. However, recently rhEPO has been reported to accelerate tumor growth, progression and metastasis. Many pituitary adenoma patients, particularly those with macroprolactinomas, tend to have anemia and may need rhEPO therapy. To date, wheth...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584615/ https://www.ncbi.nlm.nih.gov/pubmed/22086127 http://dx.doi.org/10.3892/ijo.2011.1261 |